Ahmed Itrat, MD; Ather Taqui, MD; Russell Cerejo, MD; et al.
free access
JAMA Neurol. 2016;73(2):162-168. doi:10.1001/jamaneurol.2015.3849
This observational study tested whether telemedicine is reliable and remote physician presence adequate for acute stroke treatment using a mobile stroke treatment unit.
Jan C. Purrucker, MD; Kirsten Haas, MPH, PhD; Timolaos Rizos, MD; et al.
free access
JAMA Neurol. 2016;73(2):169-177. doi:10.1001/jamaneurol.2015.3682
This multicenter observational study evaluated the early clinical and radiological course, acute management, and outcome of intracerebral hemorrhage related to non–vitamin K antagonist oral anticoagulant use.
Sepideh Amin-Hanjani, MD; Dilip K. Pandey, MD, PhD; Linda Rose-Finnell, MPA; et al.
free access
JAMA Neurol. 2016;73(2):178-185. doi:10.1001/jamaneurol.2015.3772
This longitudinal cohort study evaluates the risk for posterior circulation stroke in patients with symptomatic occlusive disease of the vertebrobasilar system.
-
Editorial
The High Risk of Low Distal Flow
James F. Meschia, MD
JAMA Neurol
Mark Fisher, MD; Lisa Moores, RN; Mohamad N. Alsharif, MD; et al.
free access
JAMA Neurol. 2016;73(2):186-189. doi:10.1001/jamaneurol.2015.3587
This study tests whether most patients with acute stroke exhibited some degree of stroke preventability.
Clinical Trial
Puck S. S. Fransen, MD; Olvert A. Berkhemer, MD; Hester F. Lingsma, PhD; et al.
free access
JAMA Neurol. 2016;73(2):190-196. doi:10.1001/jamaneurol.2015.3886
This randomized clinical trial evaluates the influence of time from stroke onset to the start of treatment and from onset to reperfusion on the effect of intra-arterial treatment in a population of patients with acute ischemic stroke.
Eitan Auriel, MD, MSc; Andreas Charidimou, MD, PhD; M. Edip Gurol, MD, MSc; et al.
free access
JAMA Neurol. 2016;73(2):197-202. doi:10.1001/jamaneurol.2015.4078
This study assesses the sensitivity and specificity of clinical and neuroimaging-based criteria for diagnosing cerebral amyloid angiopathy–related inflammation in cases and controls.
Benoit Lehallier, PhD; Laurent Essioux, PhD; Javier Gayan, PhD; et al.
free access
JAMA Neurol. 2016;73(2):203-212. doi:10.1001/jamaneurol.2015.3135
This cohort study combines diverse patient variables from the Alzheimer’s Disease Neuroimaging Initiative database to optimize prediction of midterm progression from mild cognitive impairment to Alzheimer disease dementia.
David M. Greer, MD, MA; Hilary H. Wang, BA; Jennifer D. Robinson, APRN; et al.
free access
JAMA Neurol. 2016;73(2):213-218. doi:10.1001/jamaneurol.2015.3943
This study evaluates whether hospitals have adopted the 2010 guidelines on the determination of brain death from the American Academy of Neurology and whether policy changes have taken place.